The use of sodium-glucose co-transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?
J Clin Pharm Ther
; 45(5): 883-891, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-31905245
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
/
Hypoglycemic Agents
Type of study:
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Animals
/
Humans
Language:
En
Journal:
J Clin Pharm Ther
Journal subject:
FARMACIA
/
TERAPEUTICA
Year:
2020
Document type:
Article
Affiliation country:
Greece
Country of publication:
United kingdom